Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Santoki, H"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Evaluation of Quality of Life in Patients on Different Treatment Modalities for Primary Glaucoma in a Tertiary Care Teaching Hospital- A Prospective Observational Study
    (Dr.Viral R.Dave, 2025-03) Santoki, H; Prajapati, NB; Raval, R; Shah, K; Tiwari, H; Sood, SV.
    Introduction: Glaucoma, causes irreversible vision loss, involves optic nerve damage due to increased aqueous outflow resistance in primary open-angle glaucoma (POAG) or iris blockage in primary-angle closure glaucoma (PACG). Objective: This study evaluates different treatment patterns and their effectiveness in primary glaucoma using the NEI VFQ-25. Method: A 2-month prospective observational study included patients with primary glaucoma, excluding those with secondary glaucoma or other ocular conditions. The sample size was determined based on study duration. Treatment groups received medical, laser, or surgical interventions, alone or combined. NEI VFQ-25 was administered at baseline and one month. Results: Among 100 patients, mean age 56.7 years, equally divided between POAG and PACG, QoL improved significantly across all treatment groups, greatest in medical treatment alone, multimodal treatment, least. One-way ANOVA showed difference in treatment approach on outcomes. Conclusion: Using NEI-VFQ-25, study assessed QoL in glaucoma patients across six treatment groups, finding highest QoL with medical therapy alone and lowest with combined treatments.

IMSEAR is the collaborative product of Health Literature, Library and Information Services (HELLIS) Network Member Libraries in the WHO South-East Asia Region.
HELLIS is coordinated by WHO Regional Office for South-East Asia.

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback